Cargando…
Proenkephalin A 119–159 predicts early and successful liberation from renal replacement therapy in critically ill patients with acute kidney injury: a post hoc analysis of the ELAIN trial
BACKGROUND: Renal replacement therapy (RRT) remains the key rescue therapy for critically ill patients with severe acute kidney injury (AKI). However, there are currently no tools available to predict successful liberation from RRT. Biomarkers may allow for risk stratification and individualization...
Autores principales: | von Groote, Thilo, Albert, Felix, Meersch, Melanie, Koch, Raphael, Porschen, Christian, Hartmann, Oliver, Bergmann, Deborah, Pickkers, Peter, Zarbock, Alexander |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9624047/ https://www.ncbi.nlm.nih.gov/pubmed/36316692 http://dx.doi.org/10.1186/s13054-022-04217-4 |
Ejemplares similares
-
Evaluation of Proenkephalin A 119–159 for liberation from renal replacement therapy: an external, multicenter pilot study in critically ill patients with acute kidney injury
por: von Groote, Thilo, et al.
Publicado: (2023) -
Proenkephalin a 119–159 (penKid) – a novel biomarker for acute kidney injury in sepsis: an observational study
por: Rosenqvist, Mari, et al.
Publicado: (2019) -
Proenkephalin A 119-159 (Penkid) Is an Early Biomarker of Septic Acute Kidney Injury: The Kidney in Sepsis and Septic Shock (Kid-SSS) Study
por: Hollinger, Alexa, et al.
Publicado: (2018) -
Neprilysin inhibition does not alter dynamic of proenkephalin‐A 119‐159 and pro‐substance P in heart failure
por: Arfsten, Henrike, et al.
Publicado: (2021) -
Early versus late initiation of renal replacement therapy in critically ill patients with acute kidney injury (The ELAIN-Trial): study protocol for a randomized controlled trial
por: Zarbock, Alexander, et al.
Publicado: (2016)